Evidence map›Paper›PMID 34638957›Full record

ArticleInternational journal of molecular sciences2021

Integrin β1 Promotes Pancreatic Tumor Growth by Upregulating Kindlin-2 and TGF-β Receptor-2.

Md Saimon Mia, Yagna Jarajapu, Reena Rao, Sijo Mathew

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. [Kindlin-2 regulates endometrium developmentBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Md Saimon MiaDepartment of Pharmaceutical Sciences, School of Pharmacy, North Dakota State University, Fargo, ND 58108-6050, USA.
Yagna JarajapuDepartment of Pharmaceutical Sciences, School of Pharmacy, North Dakota State University, Fargo, ND 58108-6050, USA.
Reena RaoKidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Sijo MathewDepartment of Pharmaceutical Sciences, School of Pharmacy, North Dakota State University, Fargo, ND 58108-6050, USA.
North Dakota State University · USUniversity of Kansas Medical Center · US

Funding

Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Megan Orr · 2016 to 2026
$20.5M
Regulation of Renal Response to Vasopressin by Glycogen SynthaseR01DK083525 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI RAO, REENA · 2011 to 2020
$2.5M
NIDDK NIH HHS R01 DK083525NIGMS NIH HHS 1P20GM109024, U54GM128729
6 · The paper itself

Abstract

The tumor microenvironment plays a critical role in defining the growth and malignancy of solid tumors. Extracellular matrix (ECM) proteins such as collagen, vitronectin, and fibronectin are major components of the tumor microenvironment. Tumor growth-promoting reciprocal interaction between ECM and cytoplasmic proteins is regulated by the cell surface receptors called integrins. This study investigated the mechanism by which integrin β1 promotes pancreatic tumor growth. In MIA PaCa-2 pancreatic cancer cell line, the loss of integrin β1 protein reduced the ability of cells to proliferate in a 3D matrix and compromised the ability to form a focal adhesion complex. Decreased expression of integrin α5 was observed in KO cells, which resulted in impaired cell spreading and adhesion on vitronectin and fibronectin. Reduced expression of the integrin-associated protein, kindlin-2 was also recorded. The downregulation of kindlin-2 decreased the phosphorylation of Smad2/3 by reducing the expression of TGF-β receptor 2. These results unravel a new mechanism of integrin β1 in tumor growth by modifying the expression of kindlin-2 and TGF-β receptor 2 signaling.

Indexed as

CarcinogenesisCell AdhesionCell Line, TumorCell MovementCell ProliferationExtracellular MatrixExtracellular Matrix ProteinsGene Expression Regulation, NeoplasticGene Knockout TechniquesHumansIntegrin beta1Membrane ProteinsNeoplasm ProteinsPancreatic NeoplasmsReceptor, Transforming Growth Factor-beta Type IISignal TransductionExtracellular Matrix ProteinsFERMT3 protein, humanIntegrin beta1Membrane ProteinsNeoplasm ProteinsReceptor, Transforming Growth Factor-beta Type IIintegrin β1kindlin-2pancreatic cancerTGF-β receptor

Identifiers

PMID34638957
PMCPMC8508632
OpenAlexW3204033124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.